ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness.

Ilaria Cavallari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.